Markers such as carcinoembryonic antigen (CEA) and carbohydrate 19-9 (CA19-9) do not allow for early diagnosis because of their insufficient sensitivity and specificity; these biomarkers can be affected by bacterial cholangitis and cholestasis, together with other factors (102, 103). This evidence concerns the gene CEACAM5 and cholestasis.